SCHEMBL2476685

SCHEMBL2476685

O=C(Nc1ccc(C(F)(F)F)cc1)N1CCC(c2ccc(O)cc2O)C1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 4/20 0.56
KCNH2 Q12809 2/20 0.48
CCR2 P41597 1/20 0.48
HPGDS O60760 1/20 0.47
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
TP53 P04637 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NAMPT P43490 2/20 0.46
MAPT P10636 3/20 0.46
LMNA P02545 1/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
BAZ1A Q9NRL2 1/20 0.44
EPHX2 P34913 2/20 0.44
CACNA1C Q13936 1/20 0.44
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2474761 0.88 RAB9A (0.60) NPC1RAB9ATP53SMN1; SMN2NAMPT
SCHEMBL2476936 0.85 NPC1 (0.64) NPC1RAB9ATP53SMN1; SMN2MAPT
SCHEMBL16564460 0.82 BAZ1A (0.42) TRPV1NPC1RAB9AMAPTLMNA
SCHEMBL2476185 0.81 CA12 (0.55) TRPV1NPC1RAB9ASMN1; SMN2NAMPT
SCHEMBL20271463 0.79 TRPV1 (0.63) TRPV1KCNH2HPGDSNPC1RAB9A
SCHEMBL2476567 0.78 TSHR (0.56) TRPV1NPC1RAB9ATP53SMN1; SMN2
SCHEMBL2480782 0.78 NPC1 (0.56) TRPV1NPC1RAB9ATP53SMN1; SMN2
SCHEMBL13504385 0.75 SLC9A1 (0.43) TRPV1GAA
SCHEMBL13504389 0.75 SLC9A1 (0.43) TRPV1GAA
SCHEMBL2477318 0.75 GFER (0.47) SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2373620-A1 NOVEL 4-(AZACYCLOALKYL)BENZENE-1,3-DIOL COMPOUNDS AS TYROSINASE INHIBITORS, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS Galderma Research & Development (FR) 2011-10-12 EP disclosed